| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 74,00 | 77,50 | 11:37 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | What can investors expect from ResMed, Cochlear and CSL shares this reporting season? | 5 | The Motley Fool Australia | ||
| So | COCHLEAR LIMITED: Change in substantial holding | - | ASX | ||
| 28.01. | COCHLEAR LIMITED: Application for quotation of securities - COH | 2 | ASX | ||
| 19.01. | Cochlear stock rating upgraded by RBC Capital on growth outlook | 4 | Investing.com | ||
| 19.01. | COCHLEAR LIMITED: Notice of HY26 result analyst and media briefing | 1 | ASX | ||
| COCHLEAR LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 11.01. | Cochlear shares lag the ASX 200 after a tough year. Is it time to buy? | 9 | The Motley Fool Australia | ||
| 18.12.25 | COCHLEAR LIMITED: Notification of cessation of securities - COH | - | ASX | ||
| 18.12.25 | COCHLEAR LIMITED: Notification regarding unquoted securities - COH | - | ASX | ||
| 18.12.25 | Envoy Medical, Inc.: Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant | 273 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 16.12.25 | Envoy Medical, Inc.: Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio | 250 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - December 16, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 10.12.25 | Envoy Medical, Inc.: Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant | 354 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - December 10, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 04.12.25 | Envoy Medical, Inc.: Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient | 301 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions... ► Artikel lesen | |
| 02.12.25 | Cochlear-aligned biotech off to a lacklustre start on the ASX | 6 | The Motley Fool Australia | ||
| 25.11.25 | Biocurious: Cochlear-backed Epiminder strives to raise the bar on epilepsy monitoring | 2 | Stockhead | ||
| 21.11.25 | Cochlear baut Produktmanagement aus | 5 | new business | ||
| 20.11.25 | Envoy Medical, Inc.: Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery | 462 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - November 20, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 20.11.25 | Cochlear Implant Surgery Reduces Dementia Risk by Two-thirds | 5 | BusinessKorea | ||
| 18.11.25 | Envoy Medical, Inc.: Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial | 286 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - November 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 17.11.25 | COCHLEAR LIMITED: Change in substantial holding | 1 | ASX | ||
| 12.11.25 | COCHLEAR LIMITED: Appendix 3Y - Diggory Howitt | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | DAX-Konzern Siemens Healthineers legt Zahlen vor | Siemens Healthineers startet solide ins neue Geschäftsjahr und bestätigt den Jahresausblick, wird aber vom schwachen Diagnostikgeschäft in China gebremst. Der DAX-Konzern Siemens Healthineers ist mit... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,440 | +1,65 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 24 Euro auf "Buy" belassen. Die vorläufigen Zahlen für 2025 hätten beim Umsatz und... ► Artikel lesen | |
| MEDTRONIC | 86,88 | -0,17 % | AKTIONÄR-Tipp Medtronic: Übernahme | Viel Bewegung an der Börse: Bei zahlreichen Wachstumstiteln wurden in den zurückliegenden Tagen teils deutlich Gewinne vom Tisch genommen. Der Fokus der Anleger richtet sich zusehends wieder auf defensivere... ► Artikel lesen | |
| INTUITIVE SURGICAL | 413,35 | +0,02 % | INTUITIVE SURGICAL INC - 10-K, Annual Report | ||
| TELADOC HEALTH | 4,240 | -0,05 % | Teladoc Health, Inc.: Teladoc Health to Announce Fourth Quarter 2025 Financial Results | ||
| STRAUMANN | 109,40 | -0,09 % | Straumann Holding AG: Einladung: Straumann Group Ganzjahresergebnisse 2025 Webcast | Straumann Holding AG
/ Schlagwort(e): Jahresergebnis/Quartalsergebnis
Einladung: Straumann Group Ganzjahresergebnisse 2025 Webcast
19.01.2026 / 11:00 CET/CEST
Datum:... ► Artikel lesen | |
| DEXCOM | 58,81 | -0,66 % | A Look Into DexCom Inc's Price Over Earnings | ||
| ALIGN TECHNOLOGY | 158,00 | -0,47 % | Align Technology Inc. Announces Increase In Q4 Bottom Line | WASHINGTON (dpa-AFX) - Align Technology Inc. (ALGN) reported a profit for its fourth quarter that Increases, from last yearThe company's earnings came in at $135.76 million, or $1.89 per share.... ► Artikel lesen | |
| HENRY SCHEIN | 68,60 | +1,75 % | Henry Schein Allows KKR To Buy Up To 19.9% Of Stake, Lifts Annual Outlook; Stock Up Over 8% | MELVILLE (dpa-AFX) - Henry Schein, Inc. (HSIC), a distributor of health care products and services, said on Tuesday that its Board has approved an amendment to the strategic partnership agreement... ► Artikel lesen | |
| TANDEM DIABETES | 16,270 | +0,34 % | Breaking Down Tandem Diabetes Care: 12 Analysts Share Their Views | ||
| INSULET | 204,70 | +0,05 % | INSULET CORP - 8-K, Current Report | ||
| AMBU | 11,750 | -0,59 % | Ambu A/S: Interim Report For Q1 2025/26 | 4.2.2026 07:04:05 CET | Ambu A/S |
Interim report (Q1 and Q3)
Ambu had a solid start to the 2025/26 financial year, reflected by continued strong growth momentum. Endoscopy Solutions grew by 14.4%... ► Artikel lesen |